Sihuan Pharmaceutical Holdings Group Ltd. (HKG: 0460)

Market Cap	5.10B
Revenue (ttm)	1.89B
Net Income (ttm)	-40.61M
Shares Out	9.27B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	0.04 (7.59%)
Ex-Dividend Date	Sep 27, 2024

Volume	16,460,000
Open	0.550
Previous Close	0.550
Day's Range	0.520 - 0.550
52-Week Range	0.490 - 0.710
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Sihuan Pharmaceutical Holdings Group

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics compreh...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,872
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0460

Financial Performance

In 2023, Sihuan Pharmaceutical Holdings Group's revenue was 1.86 billion, a decrease of -14.70% compared to the previous year's 2.18 billion. Losses were -54.02 million, -97.18% less than in 2022.

Financial numbers in CNY